In this issue:
- High-dose statin vs moderate-dose statin + ezetimibe in ASCVD
- Artificial intelligence-based stethoscope for the diagnosis of aortic stenosis
- Some beverages may increase the risk of cardiometabolic multimorbidity
- Cardiometabolic outcomes after COVID-19
- Clinically acquired hsTnT is a poor predictor of reduced LVEF after STEMI
- Use of FFR vs intravascular ultrasonography to guide PCI
- Use of functional stress imaging to predict abnormal coronary FFR
- Early vs delayed invasive strategy after NSTEMI
- Rivaroxaban in rheumatic heart disease-associated AF
- Percutaneous revascularisation for ischaemic left ventricular dysfunction
Please login below to download this issue (PDF)